BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3683718)

  • 1. Drug trials in migraine. The clinician's view on end points.
    Bousser MG; Baron JC
    Neuroepidemiology; 1987; 6(4):228-33. PubMed ID: 3683718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
    Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
    Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prophylactic treatments of migraine].
    Massiou H
    Rev Neurol (Paris); 2000; 156 Suppl 4():4S79-86. PubMed ID: 11139754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological synergy: the next frontier on therapeutic advancement for migraine.
    Blumenfeld A; Gennings C; Cady R
    Headache; 2012 Apr; 52(4):636-47. PubMed ID: 22221151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodological aspects of drug trials in migraine.
    Tfelt-Hansen P; Olesen J
    Neuroepidemiology; 1985; 4(4):204-26. PubMed ID: 2872606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
    Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH;
    Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of patients for clinical drug trials in migraine.
    Solomon S
    Neuroepidemiology; 1987; 6(4):164-71. PubMed ID: 3317096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms of classic migraine attacks: modifications brought about by metoprolol.
    Hedman C; Andersen AR; Andersson PG; Gilhus NE; Kangasniemi P; Olsson JE; Strandman E; Nestvold K; Olesen J
    Cephalalgia; 1988 Dec; 8(4):279-84. PubMed ID: 3064920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of oral diclofenac in the acute treatment of common migraine attacks: a double-blind study versus placebo.
    Massiou H; Serrurier D; Lasserre O; Bousser MG
    Cephalalgia; 1991 May; 11(2):59-63. PubMed ID: 1860132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Migraine Intervention Score - a tool to improve efficacy of triptans in acute migraine therapy: the ALADIN study.
    Göbel H; Heinze A
    Int J Clin Pract; 2011 Aug; 65(8):879-86. PubMed ID: 21762313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Migraine prophylactic drugs: proof of efficacy, utilization and cost.
    Ramadan NM; Schultz LL; Gilkey SJ
    Cephalalgia; 1997 Apr; 17(2):73-80. PubMed ID: 9137841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prophylactic treatment of migraine].
    Igarashi H
    Nihon Rinsho; 2005 Oct; 63(10):1809-14. PubMed ID: 16218395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodological aspects of prophylactic drug trials in migraine.
    Olesen J; Krabbe AA; Tfelt-Hansen P
    Cephalalgia; 1981 Sep; 1(3):127-41. PubMed ID: 7346180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.
    Ferrari MD; Goadsby PJ; Roon KI; Lipton RB
    Cephalalgia; 2002 Oct; 22(8):633-58. PubMed ID: 12383060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodologic issues in acute migraine clinical trials.
    Lipton RB
    Neurology; 2000; 55(9 Suppl 2):S3-7. PubMed ID: 11089512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Migraine treatment with calcium channel blockers.
    Andersson KE; Brandt L; Hindfelt B; Ryman T
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():161-7. PubMed ID: 3521194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
    Schellenberg R; Lichtenthal A; Wöhling H; Graf C; Brixius K
    Headache; 2008 Jan; 48(1):118-25. PubMed ID: 18184294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
    Raggi A; Leonardi M; Bussone G; D'Amico D
    Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol in the treatment of acute migraine attacks.
    Banerjee M; Findley L
    Cephalalgia; 1991 Sep; 11(4):193-6. PubMed ID: 1742775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic and prophylactic treatment of migraine: a critical reappraisal.
    Deleu D; Hanssens Y; Worthing EA
    Clin Neuropharmacol; 1998; 21(5):267-79. PubMed ID: 9789706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.